Generalized dystonia and chorea with family history: Clinical case
Objective: This clinical case intends to highlight the in expansion genotypic base of the genetically undefined benign hereditary chorea, where de adenylate cyclase 5 gene…Postural Stability in Blepharospasm and the Effects of Botulinum Toxin Therapy
Objective: To determine (1) how blepharospasm effects postural stability and (2) to evaluate the efficacy of botulinum toxin therapy (BoNT-A) on static balance in patients…Assessment of cognitive functions, depression-anxiety scales and quality of life in patients and their relatives with Cervical Dystonia and Botulinum Toxin Treatment
Objective: In this study, we investigated the psychiatric comorbid disorders and quality of life issues such as cognitive dysfunction accompanied by cervical dystonia and accompanying…The phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is broader than previously defined
Objective: To update the phenotype of RDP based on a cohort of ATP1A3 mutation+ individuals. Background: RDP is caused by mutations of the ATP1A3 gene,…Mingo Supplement Trial: An Open-Labeled Randomized-Controlled Trial in X-linked Dystonia-Parkinsonism patients in the Province of Capiz, Philippines
Objective: To see whether increasing the caloric intake of patients by 480 calories per day using a locally sourced food supplement, Mingo, would raise the…Impaired reaching movements in idiopathic cervical dystonia patients
Objective: Aim of the current study is to describe how patients with idiopathic cervical dystonia (CD) perform reaching movements with their upper limb (i.e. a…Does having more children really delay Parkinson’s age of onset in women?
Objective: Childbirth has been proposed to be protective of Parkinson’s (PD), in that having a higher number of children is associated with a later age…Prevalence and influence of co-pathologies in patients with autopsy-confirmed Lewy body disorders: A systematic review
Objective: To determine the prevalence of selected co-pathologies in patients with Lewy Body disorders, as well as their influence on disease expression. Background: The presence…Clinical and genetic data of Huntington disease in Uzbekistan patient
Objective: Huntington's disease (HD) occurs worldwide with prevalence varying from 0.1 to 10/100,000 depending of the ethnic origin. Since no data is available in the…Malignant gliomas in patients with Huntington’s disease
Objective: Discuss the presentation of glioblastoma multiforme in patients with Huntington’s disease Background: Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by a trinucleotide…
- « Previous Page
- 1
- …
- 157
- 158
- 159
- 160
- 161
- …
- 177
- Next Page »